Previous close | 64.76 |
Open | 65.13 |
Bid | 65.79 x 0 |
Ask | 65.88 x 0 |
Day's range | 65.13 - 65.92 |
52-week range | 53.00 - 65.92 |
Volume | |
Avg. volume | 8,755 |
Market cap | 75.482B |
Beta (5Y monthly) | 1.61 |
PE ratio (TTM) | 10.77 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.60 (7.10%) |
Ex-dividend date | 21 May 2024 |
1y target est | N/A |
(Bloomberg) -- BNP Paribas SA is considering a potential acquisition of Fosun International Ltd.’s stake in Belgian insurer Ageas, according to people with knowledge of the matter. Most Read from BloombergA $2 Billion Airport Will Test Modi’s Mission, Adani’s AmbitionsFed Seen Sticking With Three 2024 Cuts Despite Higher InflationBitcoin Extends Retreat From Record as ‘Bubble’ Talk EscalatesApple Buys Canadian AI Startup as It Races to Add FeaturesS&P 500 Falls as $5.3 Trillion Options Test Loom
Skincare company Galderma was on course to raise 2.3 billion ($2.6 billion) Swiss francs from its upcoming initial public (IPO) offering after a positive response from potential investors. The company, whose products includes Cetaphil, a product for damaged and sensitive skin, as well as fillers and skin creams, early on Wednesday announced a price range of 49 to 53 Swiss francs for its flotation - likely to be one of the biggest in Europe this year. The offering consists of up to 40.5 million new shares and 277,000 existing shares, the company said.
PARIS (Reuters) -BNP Paribas, the euro zone's largest bank, on Wednesday said it will step up its cost-cutting plans by 400 million euros ($437 million) after posting weak fourth-quarter results last month. The new plan will boost its 2022-25 savings goal to 2.7 billion euros. The additional cuts will stem from automation, lower purchases, and other areas, according to slides for a BNPP presentation scheduled today at a Morgan Stanley conference.